Reference
1. Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, et
al. Graves’ disease: Epidemiology, genetic and environmental risk
factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020:101387.
Epub 2020/02/29. doi: 10.1016/j.beem.2020.101387. PubMed PMID: 32107168.
2. Wemeau JL, Klein M, Sadoul JL, Briet C, Velayoudom-Cephise FL.
Graves’ disease: Introduction, epidemiology, endogenous and
environmental pathogenic factors. Ann Endocrinol (Paris).
2018;79(6):599-607. Epub 2018/10/22. doi: 10.1016/j.ando.2018.09.002.
PubMed PMID: 30342794.
3. Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P.
Autoimmune thyroid disorders. Autoimmun Rev. 2015;14(2):174-80. Epub
2014/12/03. doi: 10.1016/j.autrev.2014.10.016. PubMed PMID: 25461470.
4. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et
al. 2016 American Thyroid Association Guidelines for Diagnosis and
Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.
Thyroid. 2016;26(10):1343-421. Epub 2016/08/16. doi:
10.1089/thy.2016.0229. PubMed PMID: 27521067.
5. Davies TF, Ando T, Lin RY, Tomer Y, Latif R. Thyrotropin
receptor-associated diseases: from adenomata to Graves disease. J Clin
Invest. 2005;115(8):1972-83. Epub 2005/08/03. doi: 10.1172/jci26031.
PubMed PMID: 16075037; PubMed Central PMCID: PMCPMC1180562.
6. Ajjan RA, Weetman AP. The Pathogenesis of Hashimoto’s Thyroiditis:
Further Developments in our Understanding. Horm Metab Res.
2015;47(10):702-10. Epub 2015/09/12. doi: 10.1055/s-0035-1548832. PubMed
PMID: 26361257.
7. Menconi F, Marcocci C, Marino M. Diagnosis and classification of
Graves’ disease. Autoimmun Rev. 2014;13(4-5):398-402. Epub 2014/01/16.
doi: 10.1016/j.autrev.2014.01.013. PubMed PMID: 24424182.
8. Kim JJ, Yoon JW, Kim MJ, Kim SM, Hwang KR, Choi YM. Thyroid
autoimmunity markers in women with polycystic ovary syndrome and
controls. Hum Fertil (Camb). 2020:1-7. Epub 2020/01/08. doi:
10.1080/14647273.2019.1709668. PubMed PMID: 31910041.
9. Ulrich J, Goerges J, Keck C, Muller-Wieland D, Diederich S, Janssen
OE. Impact of Autoimmune Thyroiditis on Reproductive and Metabolic
Parameters in Patients with Polycystic Ovary Syndrome. Exp Clin
Endocrinol Diabetes. 2018;126(4):198-204. Epub 2018/03/06. doi:
10.1055/s-0043-110480. PubMed PMID: 29506313.
10. Pallotti S, Gasbarrone A, Franzese IT. [Relationship between
insulin secretion, and thyroid and ovary function in patients suffering
from polycystic ovary]. Minerva Endocrinol. 2005;30(3):193-7. Epub
2005/10/07. PubMed PMID: 16208308.
11. Romitti M, Fabris VC, Ziegelmann PK, Maia AL, Spritzer PM.
Association between PCOS and autoimmune thyroid disease: a systematic
review and meta-analysis. Endocr Connect. 2018;7(11):1158-67. Epub
2018/10/24. doi: 10.1530/ec-18-0309. PubMed PMID: 30352422; PubMed
Central PMCID: PMCPMC6215798.
12. Glintborg D, Rubin KH, Nybo M, Abrahamsen B, Andersen M. Increased
risk of thyroid disease in Danish women with polycystic ovary syndrome:
a cohort study. Endocr Connect. 2019;8(10):1405-15. Epub 2019/09/14.
doi: 10.1530/ec-19-0377. PubMed PMID: 31518989; PubMed Central PMCID:
PMCPMC6826171.
13. Nisar S, Shah PA, Kuchay MS, Bhat MA, Rashid A, Ahmed S, et al.
Association of polycystic ovary syndrome and Graves’ disease: Is
autoimmunity the link between the two diseases. Indian J Endocrinol
Metab. 2012;16(6):982-6. Epub 2012/12/12. doi: 10.4103/2230-8210.103006.
PubMed PMID: 23226647; PubMed Central PMCID: PMCPMC3510972.
14. Mobeen H, Afzal N, Kashif M. Polycystic Ovary Syndrome May Be an
Autoimmune Disorder. Scientifica (Cairo). 2016;2016:4071735. Epub
2016/06/09. doi: 10.1155/2016/4071735. PubMed PMID: 27274883; PubMed
Central PMCID: PMCPMC4871972.
15. Jung JH, Hahm JR, Jung TS, Kim HJ, Kim HS, Kim S, et al. A
27-year-old woman diagnosed as polycystic ovary syndrome associated with
Graves’ disease. Intern Med. 2011;50(19):2185-9. Epub 2011/10/04. doi:
10.2169/internalmedicine.50.5475. PubMed PMID: 21963738.
16. Trolle B, Flyvbjerg A, Kesmodel U, Lauszus FF. Efficacy of metformin
in obese and non-obese women with polycystic ovary syndrome: a
randomized, double-blinded, placebo-controlled cross-over trial. Hum
Reprod. 2007;22(11):2967-73. Epub 2007/09/04. doi:
10.1093/humrep/dem271. PubMed PMID: 17766923.
17. Kotwal A, Stan M. Thyrotropin Receptor Antibodies-An Overview.
Ophthalmic Plast Reconstr Surg. 2018;34(4S Suppl 1):S20-s7. Epub
2018/05/18. doi: 10.1097/iop.0000000000001052. PubMed PMID: 29771756.
18. Fairweather D, Rose NR. Women and autoimmune diseases. Emerg Infect
Dis. 2004;10(11):2005-11. Epub 2004/11/20. doi: 10.3201/eid1011.040367.
PubMed PMID: 15550215; PubMed Central PMCID: PMCPMC3328995.
19. Cutolo M, Sulli A, Straub RH. Estrogen metabolism and autoimmunity.
Autoimmun Rev. 2012;11(6-7):A460-4. Epub 2011/12/14. doi:
10.1016/j.autrev.2011.11.014. PubMed PMID: 22155198.
20. Gilbert EW, Tay CT, Hiam DS, Teede HJ, Moran LJ. Comorbidities and
complications of polycystic ovary syndrome: An overview of systematic
reviews. Clin Endocrinol (Oxf). 2018;89(6):683-99. Epub 2018/08/14. doi:
10.1111/cen.13828. PubMed PMID: 30099747.
21. Forslund M, Landin-Wilhelmsen K, Trimpou P, Schmidt J, Brannstrom M,
Dahlgren E. Type 2 diabetes mellitus in women with polycystic ovary
syndrome during a 24-year period: importance of obesity and abdominal
fat distribution. Hum Reprod Open. 2020;2020(1):hoz042. Epub 2020/01/25.
doi: 10.1093/hropen/hoz042. PubMed PMID: 31976382; PubMed Central PMCID:
PMCPMC6964225.
22. Rimmer M, Tan BK, Teede H, Thangaratinam S, B HAW. Metabolic
inflexibility in women with polycystic ovary syndrome: a systematic
review. Gynecol Endocrinol. 2019:1-7. Epub 2019/12/04. doi:
10.1080/09513590.2019.1698025. PubMed PMID: 31793357.
23. Gonzalez F, Considine RV, Abdelhadi OA, Acton AJ. Inflammation
triggered by saturated fat ingestion is linked to insulin resistance and
hyperandrogenism in PCOS. J Clin Endocrinol Metab. 2020. Epub
2020/03/07. doi: 10.1210/clinem/dgaa108. PubMed PMID: 32140727.
24. Matarese G, Leiter EH, La Cava A. Leptin in autoimmunity: many
questions, some answers. Tissue Antigens. 2007;70(2):87-95. Epub
2007/07/06. doi: 10.1111/j.1399-0039.2007.00886.x. PubMed PMID:
17610413.
25. Chen SF, Yang YC, Hsu CY, Shen YC. Risk of schizophrenia in patients
with polycystic ovary syndrome: a nationwide population-based cohort
study from Taiwan. J Psychosom Obstet Gynaecol. 2020:1-7. Epub
2020/03/07. doi: 10.1080/0167482x.2020.1735342. PubMed PMID: 32141403.
26. Chen SF, Yang YC, Hsu CY, Shen YC. Risk of bipolar disorder in
patients with polycystic ovary syndrome: A nationwide population-based
cohort study. J Affect Disord. 2020;263:458-62. Epub 2020/01/24. doi:
10.1016/j.jad.2019.12.007. PubMed PMID: 31969278.
27. Cooney LG, Dokras A. Depression and Anxiety in Polycystic Ovary
Syndrome: Etiology and Treatment. Curr Psychiatry Rep. 2017;19(11):83.
Epub 2017/09/21. doi: 10.1007/s11920-017-0834-2. PubMed PMID: 28929349.
28. Greenwood EA, Pasch LA, Cedars MI, Legro RS, Huddleston HG.
Association among depression, symptom experience, and quality of life in
polycystic ovary syndrome. Am J Obstet Gynecol. 2018;219(3):279.e1-.e7.
Epub 2018/07/04. doi: 10.1016/j.ajog.2018.06.017. PubMed PMID: 29969586;
PubMed Central PMCID: PMCPMC6758922.
29. Hsing AW, Ioannidis JP. Nationwide Population Science: Lessons From
the Taiwan National Health Insurance Research Database. JAMA Intern Med.
2015;175(9):1527-9. Epub 2015/07/21. doi:
10.1001/jamainternmed.2015.3540. PubMed PMID: 26192815.
30. Li Q, Yang G, Wang Y, Zhang X, Sang Q, Wang H, et al. Common genetic
variation in the 3’-untranslated region of gonadotropin-releasing
hormone receptor regulates gene expression in cella and is associated
with thyroid function, insulin secretion as well as insulin sensitivity
in polycystic ovary syndrome patients. Hum Genet. 2011;129(5):553-61.
Epub 2011/01/29. doi: 10.1007/s00439-011-0954-4. PubMed PMID: 21274726.
Figure 1. The cumulative incidence of Graves’s diseases in patients with
and without PCOS.
Table 1. Baseline characteristics of non-PCOS cohort and PCOS cohort.